Search research articles
Contact Us
Filters
Showing results (201-210 of 258) with videos related to
Page
of 26
Sort By:
Oncotarget
|
March 28, 2018
Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth <i>in vitro</i> and <i>in vivo</i>: a preliminary report
Giovani M Favero, Jessica L Paz, Andréia H Otake, et al.
ESMO Open
|
March 5, 2022
Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
S Senan, M Özgüroğlu, D Daniel, et al.
ESMO Open
|
February 24, 2022
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
E Heitzer, D van den Broek, M G Denis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2007
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
J Bellmunt, L Paz-Ares, M Cuello, et al.
Revista De Neurologia
|
January 11, 2002
[Clinical characteristics of drug induced parkinsonism in psychotic patients]
J L Giroud-Benítez, R M López-Suárez, A Méndez-Chávez, et al.
ESMO Open
|
May 20, 2021
Impact of the COVID-19 pandemic on the care of cancer patients in Spain
M Amador, X Matias-Guiu, G Sancho-Pardo, et al.
ESMO Open
|
June 25, 2023
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
J R Gosney, L Paz-Ares, P Jänne, et al.
ESMO Open
|
April 30, 2021
Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours
L Paz-Ares, F Barlesi, S Siena, et al.
ESMO Open
|
June 30, 2023
Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results
E B Garon, M Reck, K Nishio, et al.
Microbial Pathogenesis
|
June 29, 2024
The polymicrobial nature of the oral cavity and claws of cats diagnosed by mass spectrometry and next-generation sequencing
Fábio V R Portilho, Juliano Nóbrega, Beatriz O de Almeida, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 258) with videos related to
Sort By:
Page
of 26
Oncotarget
|
March 28, 2018
Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth <i>in vitro</i> and <i>in vivo</i>: a preliminary report
Giovani M Favero, Jessica L Paz, Andréia H Otake, et al.
ESMO Open
|
March 5, 2022
Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
S Senan, M Özgüroğlu, D Daniel, et al.
ESMO Open
|
February 24, 2022
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
E Heitzer, D van den Broek, M G Denis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 19, 2007
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
J Bellmunt, L Paz-Ares, M Cuello, et al.
Revista De Neurologia
|
January 11, 2002
[Clinical characteristics of drug induced parkinsonism in psychotic patients]
J L Giroud-Benítez, R M López-Suárez, A Méndez-Chávez, et al.
ESMO Open
|
May 20, 2021
Impact of the COVID-19 pandemic on the care of cancer patients in Spain
M Amador, X Matias-Guiu, G Sancho-Pardo, et al.
ESMO Open
|
June 25, 2023
Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation
J R Gosney, L Paz-Ares, P Jänne, et al.
ESMO Open
|
April 30, 2021
Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours
L Paz-Ares, F Barlesi, S Siena, et al.
ESMO Open
|
June 30, 2023
Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results
E B Garon, M Reck, K Nishio, et al.
Microbial Pathogenesis
|
June 29, 2024
The polymicrobial nature of the oral cavity and claws of cats diagnosed by mass spectrometry and next-generation sequencing
Fábio V R Portilho, Juliano Nóbrega, Beatriz O de Almeida, et al.
Page
of 26